Literature DB >> 30864829

SDF1/CXCR7 Signaling Axis Participates in Angiogenesis in Degenerated Discs via the PI3K/AKT Pathway.

Hanxiang Zhang1, Peng Wang1, Xiang Zhang1, Wenrui Zhao1, Honglei Ren1, Zhenming Hu1.   

Abstract

Degenerative disc disease (DDD) is the main cause of low back pain, and the ingrowth of new blood vessels is one of its pathological features. The stromal cell-derived factor 1 (SDF1)/CXCR7 signaling axis plays a role in these physiological and pathological activities. The aims of this study were to explore whether this signaling axis participates in the angiogenesis of degenerated intervertebral discs (IVDs) and to define its underlying mechanism. In this study, we cocultured human nucleus pulposus cells (NPCs) and vascular endothelial cells (VECs) and regulated the expression of SDF1/CXCR7 to investigate the effect of VEC angiogenesis by NPCs. The results revealed that angiogenesis was enhanced with increased SDF1 and that angiogenesis was weakened with the inhibition of CXCR7. We found that PI3K/AKT was involved in the downstream pathway in the coculture. VEC angiogenesis induction by NPCs was enhanced with an increase in pAKT or a decrease in PTEN. We conclude that the SDF1/CXCR7 signaling axis plays a role in the angiogenesis of degenerated IVD through the PI3K/AKT pathway.

Entities:  

Keywords:  CXCR7; PI3K/AKT; angiogenesis; degenerated disc; stromal cell-derived factor 1 (SDF1)

Mesh:

Substances:

Year:  2019        PMID: 30864829     DOI: 10.1089/dna.2018.4531

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

1.  High-Throughput Sequencing Reveals CXCR4 and IGF1 Behave Different Roles in Weightlessness Osteoporosis.

Authors:  Dong Wang; Weihang Li; Ziyi Ding; Quan Shi; Shilei Zhang; Zhuoru Zhang; Zhibin Liu; Xiaocheng Wang; Ming Yan
Journal:  Stem Cells Int       Date:  2022-04-18       Impact factor: 5.131

2.  Role of lncRNA XIST/microRNA-19/PTEN network in autophagy of nucleus pulposus cells in intervertebral disc degeneration via the PI3K/Akt signaling pathway.

Authors:  Wei Chen; Shaoguang Li; Feng Zhang
Journal:  Cell Cycle       Date:  2021-08-12       Impact factor: 5.173

3.  Silencing MicroRNA-137-3p, which Targets RUNX2 and CXCL12 Prevents Steroid-induced Osteonecrosis of the Femoral Head by Facilitating Osteogenesis and Angiogenesis.

Authors:  Lingchi Kong; Rongtai Zuo; Mengwei Wang; Wenbo Wang; Jia Xu; Yimin Chai; Junjie Guan; Qinglin Kang
Journal:  Int J Biol Sci       Date:  2020-01-14       Impact factor: 6.580

4.  Stromal cell-derived factor-1 regulates the secretion of interleukin-1β in the temporomandibular joint of rats with synovial inflammation.

Authors:  Dong Qi; Shuzhen Sun; Liang Han; Qiang Wang; Jingjing Kong; Yujun Zhang; Ronglin Wang; Yan Chen; Ping Ji
Journal:  J Oral Pathol Med       Date:  2020-06-13       Impact factor: 4.253

5.  Optimal H2O2 preconditioning to improve bone marrow mesenchymal stem cells' engraftment in wound healing.

Authors:  Ling Guo; Juan Du; Dan-Feng Yuan; Ya Zhang; Shu Zhang; Hua-Cai Zhang; Jun-Wei Mi; Ya-Lei Ning; Min-Jia Chen; Da-Lin Wen; Jian-Hui Sun; Di Liu; Ling Zeng; Anqiang Zhang; Jianxin Jiang; Hong Huang
Journal:  Stem Cell Res Ther       Date:  2020-10-08       Impact factor: 6.832

6.  SDF1/CXCR4 axis facilitates the angiogenesis via activating the PI3K/AKT pathway in degenerated discs.

Authors:  Hanxiang Zhang; Peng Wang; Xiang Zhang; Wenrui Zhao; Honglei Ren; Zhenming Hu
Journal:  Mol Med Rep       Date:  2020-09-09       Impact factor: 2.952

7.  The Role of miR-31-5p in the Development of Intervertebral Disc Degeneration and Its Therapeutic Potential.

Authors:  Yong Zhou; Mingsi Deng; Jiqing Su; Wei Zhang; Dongbiao Liu; Zhengguang Wang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 8.  Steroid-Induced Osteonecrosis of the Femoral Head: Novel Insight Into the Roles of Bone Endothelial Cells in Pathogenesis and Treatment.

Authors:  Cheng Huang; Zeqin Wen; Junjie Niu; Subin Lin; Weiguo Wang
Journal:  Front Cell Dev Biol       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.